It is known that antivirals are valuable supplementation to vaccines for the control and prevention of influenza [1] , and are likely to be active against a new pandemic variant [2] . Oseltamivir phosphate (Figure 1 ) is the best known orally active neuraminidase inhibitor antiviral drug [3, 4] that slows the spread of influenza virus between cells in the body by stopping the virus from chemically cutting ties with its host-cell median time to symptom alleviation is reduced by 0.5-1 days [5] . The neuraminidase inhibitors are effective against both influenza A and B and are considered less toxic and less likely to promote development of drug-resistant influenza than adamantanes [6] . Oseltamivir phosphate can be identified by thin--layer chromatography, specific optical rotation, infrared spectrophotometry and tests characteristic for orthophosphates [7] . Determination, by International Pharmacopeia, can be done by high-performance liquid chromatography [7, 8] or by titration with perchloric acid [7] .
Other methods include capillary electrophoresis [9] , spectrofluorometry [10] , micellar electrokinetic chromatography [11] , colorimetric [12] and liquid chromatographic methods [12, 13] . CH 3 OH and NaHCO 3 were of analytical grade (Merck). The supporting electrolyte, 0.05 M NaHCO 3 was prepared with 18 MΩ deionised water.
Apparatus
Standard equipment was used for the cyclic voltammetry measurements using a three electrode electrochemical cell, as previously described in detail [15] [16] [17] . Polycrystalline gold (surface area 0.500 cm 2 ) and glassy carbon Sigmadur GMBH Germany (surface area 0.29 cm 2 ) which served as the working electrodes were prepared as earlier [15] [16] [17] . A gold wire was used as the counter electrode and a saturated calomel electrode as the reference electrode. All the potentials are given versus SCE. The electrolyte was deoxygenated by purging with nitrogen.
The characteristics of the HPLC instrument are already described in detail [15] [16] [17] and the HPLC method performed during the simultaneous electrochemical experiment for oseltamivir determination has been published by Lindegardh et al. [14] .
RESULTS AND DISCUSSION
In our study of electrochemical behavior of oseltamivir phosphate and development of the appropriate method, a solution of oseltamivir phosphate standard was prepared as described in the Experimental part and used in the cyclic voltammetry measurements. In the first part of the work the gold electrode was used. The cyclic voltammogram of the clean gold electrode of oseltamivir phosphate (0.025 mg cm -3 ) is presented in Figure 2 . Simultaneous HPLC analysis of the bulk of electrolyte confirmed that 0.025 mg cm -3 oseltamivir phosphate is presented in the electrolyte. Starting from -1.2 V one can observe an apparent reversible oxidative/reductive reaction between -0.5 and -0.7 V. In the anodic direction, the anodic current increases from 0.4 V and reaches the maximum starting from the area of the oxides formation. In the entire region of oxides formation at the gold electrode, the oxidative activity of oseltamivir phosphate is obvious. The lowering of the oxides reduction currents can also be noticed from the cyclic voltammogram. Starting from -0.8 V the exact same reactions were observed as it was obtained starting from -1.2 V, and as it is presented in Figure 3 . The potential was cycled continuously for two hours and the cyclic voltammogram was quite stable in both cases. Holding the potential for 10 min at the peak potentials and in the area of oxide formation did not affect the voltammogram even in the first sweep. The cyclic voltammogram of oseltamivir phosphate at the gold electrode in 0.05 M NaHCO 3 (Figures 2 and 3) is quite reproducible.
With the addition of the next two aliquotes of stock solution of oseltamivir phosphate containing 2.5 mg cm -3 , the linearity of the current-concentration dependency was not observed, and even the voltammogram remained the same. With the simultaneous HPLC analysis of the bulk of electrolyte, the presence of the added concentrations was confirmed. Additionally, the glassy carbon electrode was tested as a working electrode in the same manner of the electrode cleaning and under identical experimental condi-tions as it was presented for the gold electrode. Starting from -1.2 V as well as from -0.8 V in the presence of 0.025 mg cm -3 oseltamivir phosphate the cyclic voltammogram of glassy carbon electrode was the same as without it. The non-pretreated glassy carbon electrode cannot be used as the working electrode.
In addition, the determination of oseltamivir phosphate in Tamiflu ® capsules was performed at the gold electrode. The cyclic voltammograms of the gold electrode in a presence of 0.025 mg cm -3 Tamiflu ® were surprisingly the same as given for 0.025 mg cm -3 of oseltamivir phosphate standard (Figures 2 and 3) . The cyclic voltammogram of Tamiflu ® also remain stable during the cycling. With the addition of the next two aliquots of stock solution of Tamiflu ® the voltammogram remaines the same and with the simultaneous HPLC analysis of the bulk of electrolyte, the presence of the added concentrations was confirmed.
The cyclic voltammograms of Tamiflu ® are quite reproducible. According to identical cyclic voltammograms of oseltamivir phosphate standard (Figures 2 and  3 ) and Tamiflu ® capsule content it is evident that oseltamivir phosphate can be qualitatively determined in capsule Tamiflu ® at gold electrode in 0.05 M NaHCO 3 . The excipients presented in Tamiflu  capsules: talk, sodium stearil fumarate, corn starch and sodium croscarmelose are insoluble in water [18] . Besides oseltamivir phosphate, only povidon is soluble in water, but it is obvious that it is not electroactive under the conditions presented in Figure 2 . The excipients were separately tested in our previous investigations [15] [16] [17] 19] concerning commercial pharmaceutical compounds. The present excipients did not affect the electroactivity of oseltamivir phosphate in Tamiflu ® capsule. It is qualitatively determined as the component of the capsule Tamiflu ® Roche in the same way as the pure standard. The qualitative determination of oseltamivir phosphate as standard and in Tamiflu ® capsule in any case should not be compared with our previously published results concerning qualitative determination of macrolide antibiotics [15] [16] [17] obtained under the same experimental conditions. Azithromycin, clarithromycin and erythromycin are strongly dependent on the starting potential -1.2 V and with the starting potential -0.8 V, they are completely inactive on the gold electrode. The peak potentials, peak height and peak reversibility are quite different for each antibiotic standard as well as for oseltamivir phosphate standard. Antibiotics in capsules and tablets in the presence of the excipients exhibit significantly different electrochemical behavior and consequently the different cyclic volltamograms comparing to their standards. Only oseltamivir phosphate exhibits the quite same cyclic voltammogram as a standard and as a content of Tamiflu ® capsule.
CONCLUSION
In conclusion, it should be pointed out that a simple and fast voltammetric method for the qualitative determination of oseltamivir phosphate was developed and applied for the qualitative determination of oseltamivir phosphate in Tamiflu ® capsules. Starting from -1.2 V as well as from -0.8 V, an apparent reversible oxidetive/reductive reaction between -0.5 and -0.7 V occurs. In the anodic direction, the anodic current increases from 0.4 V and reaches a maximum starting from the area of the oxides formation. In the entire region of the oxides formation at the gold electrode this maximum oxidative currents of oseltamivir phosphate remain unchanged. The lowering of the oxides reduction currents is also noticed. The identical cyclic voltammograms of oseltamivir phosphate standard and of Tamiflu ® capsule content showed that oseltamivir phosphate is quailtatively determined in Tamiflu ® capsule content at the gold electrode in 0.05 M NaHCO 3 . The glassy carbon electrode cannot be used as working electrode and did not exhibited any affinity to the oxidative/reductive reactions of oseltamivir phosphate starting from -1.2 V as well as from -0.8 V.
